Brief report on use of pembrolizumab with or without chemotherapy for advanced lung cancer: A real-world analysis
Authors
Monika A. Izano, Syapse, San Francisco, CA, USA. Electronic address: Monika.Izano@syapse.com.
Connor Sweetnam, Syapse, San Francisco, CA, USA.
Chenan Zhang, Syapse, San Francisco, CA, USA.
James L. Weese, Advocate Aurora HealthFollow
Douglas Reding, Ascension, Milwaukee, WI.
Jonathan Treisman, Ascension, Milwaukee, WI.
Anand Patel, Ascension, Milwaukee, WI.
Bindu Potugari, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA.
Andrew Stafford, Syapse, San Francisco, CA, USA.
Frank M. Wolf, Syapse, San Francisco, CA, USA.
Mary Tran, Syapse, San Francisco, CA, USA.
Thomas D. Brown, Syapse, San Francisco, CA, USA.Follow
Shirish M. Gadgeel, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA.
Recommended Citation
Izano MA, Sweetnam C, Zhang C, et al. Brief Report on Use of Pembrolizumab With or Without Chemotherapy for Advanced Lung Cancer: A Real-World Analysis. Clin Lung Cancer. 2023;24(4):362-365. doi:10.1016/j.cllc.2023.01.011
